ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Manager, QC Analytical Support & Investigations at Ocular Therapeutix - ApplyBlast

Senior Manager, QC Analytical Support & Investigations

Ocular Therapeutix

2 days ago

4.1 on Glassdoor

Bedford, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Manager, QC Analytical Support & Investigations provides investigation oversight and analytical problem-solving support across the Quality Control organization. This role serves as a central resource for managing Out-of-Specification (OOS), Out-of-Trend (OOT), laboratory deviations, and other significant laboratory events. The position partners with cross-functional teams to ensure investigations are scientifically sound, properly documented, and completed in a timely manner with effective root-cause analysis and corrective actions.

Responsibilities

Oversee QC laboratory investigations and root-cause analysis
Lead cross-functional investigations and CAPA management
Establish investigation standards and coach QC teams

Skills

Qualifications

Bachelor's degree in Chemistry, Biochemistry, Biology, Microbiology, Pharmaceutical Sciences, Chemical Engineering, or related scientific disciplineMaster's degree or advanced scientific degree

About Ocular Therapeutix

ocutx.com

Headquarters

Bedford, Massachusetts, United States

Company Size

51-200 employees

Founded

2006

View Profile

Ocular Therapeutix is an ophthalmic biopharmaceutical company focused on developing innovative treatments for retinal diseases. Its lead program, AXPAXLI™, is a sustained‑release hydrogel therapy in development as a potential treatment for wet age‑related macular degeneration (wet AMD), designed to extend drug exposure and reduce injection frequency. The company develops and aims to commercialize ophthalmic products that improve outcomes for people with retinal disease. Ocular Therapeutix combines drug formulation and ocular drug‑delivery technology to redefine treatment approaches in retinal care.